TP53 and cancer: The tumor suppressor p53, known as the “Guardian of genome”, still appears to be one of the major therapeutic targets for cancer due to its strong anticancer ability to respond to various cellular stress such as high reactive oxygen species (ROS), DNA damage, genomic instability, and senescence [8,9,10].